Dr. Jeff Chapman currently holds the position of Senior Director, CE Business, at SCIEX, a Danaher Company. Jeff and his team are responsible for the development, manufacturer, sales and support of electrodriven microscale separations technology at SCIEX. Jeff holds B.Sc. and Ph.D. degrees in Biochemistry, Immunology and Neuroimmunology from the University of Saskatchewan and the University of Calgary. He joined Beckman Instruments in 1989 in Mississauga, where he was responsible for introducing Capillary Electrophoresis (CE) technology to Scientists across Canada. In 1995, he moved to Southern California, where he took on worldwide responsibility for CE. Beginning in 1998, Jeff moved into the development side of Beckman Coulter and has held the positions of Product Manager, Strategic Marketing Manager, Director of Scientific Alliances and Director of Global Marketing. Jeff transitioned the CE business over to SCIEX in 2013, integrating CE with nano-LC and micro-LC to form one of the largest microscale separations operations in the World. Dr. Chapman has more than 30 years of experience with CE technology over his career, has served on myriad scientific committees and boards on this topic, and is cited often as an industry expert in this field. He is also serving currently as a member of the Strategic Planning Committee for MicroScale Bioseparations.